GOSS vs ZTS · rev $26.2M vs P/E 25, rev $2.47B
Gossamer Bio Inc (GOSS) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
GOSS currently screens at market cap $47.0M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the GOSS and ZTS stock pages for the full models.
Not investment advice.